RS6041735 Unknown gene

Other Chr ?:?
Upload your DNA to see your genotype for this variant.
GWAS Studies (17)
Trait Risk Allele OR / Beta P-value Study
Dihydroceramide (d18:0/18:0) levels C OR: 0.17 4E-13 PubMed
Sphingomyelin (37:2) levels C OR: 0.16 5E-12 PubMed
Ceramide(40:2)_[M-H]1- levels A OR: 0.11 5E-11 PubMed
Ceramide(40:1)_[M-H]1- levels C β: 0.089 5E-11 PubMed
Ceramide(40:0)_[M-H]1- levels G β: 0.034 5E-11 PubMed
Ceramide(41:2)_[M-H]1- levels G β: 0.03 5E-11 PubMed
Ceramide(41:1)_[M-H]1- levels T β: 0.09 5E-11 PubMed
Ceramide(41:0)_[M-H]1- levels G β: 0.055 5E-11 PubMed
Ceramide(42:0)_[M-H]1- levels T β: 0.068 5E-11 PubMed
Sphingomyelin(37:1)_[M-CH3]1- levels A β: 0.044 5E-11 PubMed
Sphingomyelin(37:1)_[M+H]1+ levels A β: 0.085 5E-11 PubMed
Sphingomyelin(39:1)_[M-CH3]1- levels G OR: 0.11 5E-11 PubMed
Sphingomyelin(38:1)_[M+H]1+ levels A β: 0.032 5E-11 PubMed
Sphingomyelin(39:1)_[M+H]1+ levels A β: 0.041 5E-11 PubMed
Phosphatidylcholine-O(36:1)_[M+H]1+/Phosphatidylethanolamine-O(39:1)_[M+H]1+/Phosphatidylcholine-P(36:0)_[M+H]1+ levels T β: 0.034 5E-11 PubMed
Ceramide (d18:1/18:0) levels C OR: 0.15 1E-10 PubMed
Sphingomyelin (d18:0/18:0, d19:0/17:0) levels 6E-7 PubMed
Ask Dr. Hemsworth about this variant